• Welcome to Sanovi Pharmaceuticals
  • +91 9900284769
  • sales@sanovipharmaceuticals.com
Get a Quote
about-img

Welcome to
Sanovi Pharmaceuticals Pvt. Ltd.

Sanovi Pharmaceuticals Pvt Ltd, Bangalore-India, Sanovi Pharmaceuticals Private Limited is owned by R&D experienced Techno-entrepreneurs. We have wide range of Specialty chemicals, Key starting Materials and Regulatory intermediates in our portfolio to offer. Having proffesional knowledge on the quality and regulatory aspects. We have strong technical team for Process development of key starting materials, pharmaceutical advanced intermediates and APIs.

Read More
WHY CHOOSE US

OUR QUALITY POLICY

  • The Company shall establish and maintain high standards of quality for its products manufactured at various sites, including those at contract manufacturing sites, meeting cGMP and cGLP norms.
  • Products shall be manufactured and marketed meeting all quality parameters related to identity, purity, safety and efficiency through well-defined quality assurance and validated systems.
RESEARCH & DEVELOPMENT

We are focused on undertaking dedicated R&D in areas with significant industrial demand, Our synthetic approach to the process development

Our Vision

To render best services to Global Pharma companies by providing best quality suppliers for Fine Chemicals, Raw materials and Intermediates/ APIs.

Our Mission

It is our endeavour to develop products and offer quality services to create substantial value for the company. Our key objective is timely delivery, quick and prompt .

Partnership Oriented Approach

We forge mutually beneficial partnerships that provide full transparency

Our Products

Active Pharmaceutical (API's)

We are engaged in the Sanovi of offering to our patrons a broad range of Active Pharmaceutical Ingredients.

Read More
Fine Chemcial Components

We at Sanovi Pharmaceuticals Pvt Ltd, offer a wide range of products, which includes Fingerprint, RFID, Palm and Facial Time & Attendance.

Read More
Intermediates

A reaction intermediate or an intermediate is a molecular entity that is formed from the reactants (or preceding intermediates)

Read More

Sanovi Pharmaceuticals Pvt. Ltd. Bengaluru.

20%

Export Percentage

2019

Year of Establishment

3498

Satisfied Clients

8

Major Markets in the country

7894

Number of Employees

The Products List


API Advance Intermediates and KSMs
S. No. Name of Product CAS Number Structure Category of the Product Application
1 1,6-di-(tert-butoxycarbonyl)-ergoline-8beta-carboxylic acid 1075250-76-8 Structure 1 Advance Intermediate (N-3 Intermediate) Cabergoline
2 6-Allyl-8-beta-carboxy-ergoline 81409-74-7 Structure 2 Advance Intermediate (N-2 Intermediate) Cabergoline
3 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC Free Base) 1892-57-5 Structure 3 Key Starting Material Cabergoline
4 1-(4,5-Diamino-10-aza-tricyclo[6.3.1.0]dodeca-2,4,6-trien-10-yl)-2,2,2-trifluoro-ethanone 230615-69-7 Structure 4 Advance Intermediate (N-3 Intermediate) Varenicline
5 1-(9,10-Dihydro-6H-6,10-methano azepino[4,5-g]quinoxalin-8 (7H)-yl)-2,2,2-trifluoroethanone 230615-70-0 Structure 5 Advance Intermediate (N-2 Intermediate) Varenicline
6 (R)-tert-Butyl 1-(Benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate 880468-89-3 Structure 6 Intermediate Lacosamide
7 4-(trifluoromethoxy)benzenamine 93919-56-3 Structure 7 Intermediate Riluzole
8 (S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran 915095-94-2 Structure 8 Advance Intermediate (N-2 Intermediate) Empagliflozin
9 (3S)-3-[4-(5-Bromo-2-chlorobenzyl)phenoxy]tetrahydrofuran 915095-89-5 Structure 9 Advance Intermediate (N-2 Intermediate) Empagliflozin
10 1-Chloro-2-(4-ethoxybenzyl)-4-bromobenzene 461432-23-5 Structure 10 Key Starting Material Dapagliflozin
11 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene 1103738-29-9 Structure 11 Key Starting Material Dapagliflozin
12 1-[2-Amino-1-(4-methoxyphenyl)-ethyl]-cyclohexanol hydrochloride 130198-05-9 Structure 12 Advance Intermediate (N-2 Intermediate) Venlafaxine
13 4-acetyl-2-methylbenzonitrile 1138444-80-0 Structure 13 Key Starting Material Fluralaner
14 3',5'-Dichloro-2,2,2-trifluoroacetophenone 130336-16-2 Structure 14 Key Starting Material Fluralaner / Fluxametamide
15 2-amino-N-(2,2,2-trifluoroethyl) acetamide hydrochloride 1171331-39-7 Structure 15 Intermediate Fluralaner / Lotilaner
16 4-acetyl-1-naphthoic acid 131986-05-5 Structure 16 Key Starting Material Umifoxolaner
17 3'-chloro-5'-trifluoromethyl-2,2,2-trifluoroacetophenone 1125812-58-9 Structure 17 Intermediate Afoxolaner
18 DL-1,4-Dithiothreitol 3483-12-3 Structure 18 Reducing Agent Lefamulin acetate / Mertansine / Setmelanotide / Eptifibatide
CDMO Molecules (Building Blocks) – New Molecule Fragments
No. Chemical Name CAS Number Structure Type Application
19 Glycine tert-butyl ester hydrochloride 27532-96-3 Structure 19 Building Block For New Molecule
20 4-Iodo-2-Fluoroaniline 29632-74-4 Structure 20 Building Block For New Molecule
21 4-bromo-2-Fluoroaniline 367-24-8 Structure 21 Building Block For New Molecule
22 4-Amino-3-fluorophenylboronic acid, pinacol ester 819058-34-9 Structure 22 Building Block For New Molecule
23 (2-Fluoro-4-iodo-phenyl)-carbamic acid tert-butyl ester 886497-72-9 Structure 23 Building Block For New Molecule
25 4-(BOC-amino)-3-fluorophenyl boronic acid, pinacol ester 262444-42-8 Structure 25 Building Block For New Molecule
26 4,6-Dimethoxy-pyridin-3-ylamine 50503-42-9 Structure 26 Building Block For New Molecule
27 2,4-Dichloro-5-nitro-pyridine 4487-56-3 Structure 27 Building Block For New Molecule
28 2-Phenylthio benzoic acid 1527-12-4 Structure 28 Key Starting Material Metixene
29 3-Bromo-Quinoline 5332-24-1 Structure 29 Key Starting Material Vodobatinib (P-3)
30 2,3-Diaminopyridine 452-58-4 Structure 30 KSM/Intermediate Rimegepant
31 Dimethyl-3-bromophtalate 58749-33-0 Structure 31 Building Block For New Molecule
32 (S)-tert-butyl 4,5-diamino-5-oxopentanoate hydrochloride (H-Glu (OtBu)-NH₂.HCl) 108607-02-9 Structure 32 Building Block For New Molecule
33 6-Fluoronaphthalen-1-ol 804498-72-4 Structure 33 Building Block For new molecule / under clinical study

Send Us Message!

Please complete the following details

Bala Krishana

I have been impressed with the proactivity and the desire to get things done that has been shown by each one of the Sanovi Pharma team with whom I have interacted. My experience with Sanovi Pharmaceuticals.

testimonial-img
Hari Lumar

I have been impressed with the proactivity and the desire to get things done that has been shown by each one of the Sanovi Pharma team with whom I have interacted. My experience with Sanovi Pharmaceuticals.

testimonial-img
Bhanuprakash

I have been impressed with the proactivity and the desire to get things done that has been shown by each one of the Sanovi Pharma team with whom I have interacted. My experience with Sanovi Pharmaceuticals.

testimonial-img